3 ETFs Tipped for 10% or More Gains by AI Analyst
Exchange-traded funds (ETFs) offer a key way to enter financial markets. For investors looking for a starting point to tap into the growth potentia...
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 146,904 | $38,891,413 | -1% | 0.79% |
| 2. | Sivik Global Healthcare Krishen Sud | 24,000 | $6,353,760 | +20% | 3.63% |
| 3. | Zevenbergen Capital Investments Nancy Zevenbergen | 11,139 | $2,948,939 | +1% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $206.15 | 1,250 | $257,687.50 | 1,849 | 2025-11-26 | Filing | |
| $145.53 | 100 | $14,553.00 | 250 | 2024-04-30 | Filing | |
| $147.22 | 1,000 | $147,220.00 | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | $63,843.00 | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | $706,399.00 | 5,000 | 2019-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $274.74 | 22,527 | $6,189,067.98 | 25,447 | 2026-09-02 | Filing | |
| $274.74 | 11,070 | $3,041,371.80 | 25,447 | 2026-09-02 | Filing | |
| $263.36 | 15,000 | $3,950,400.00 | 194,451 | 2026-08-17 | Filing | |
| $261.00 | 102,315 | $26,704,215.00 | 275,967 | 2026-08-13 | Filing | |
| $262.00 | 20,976 | $5,495,712.00 | 378,282 | 2026-08-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 709,904 | $187,939,985 | 4.66% | |
| 2. | 666,675 | $176,495,471 | 2.11% | |
| 3. | 643,935 | $170,475,322 | 2.28% | |
| 4. | 322,616 | $85,409,247 | 7.64% | |
| 5. | 299,306 | $79,238,277 | 1.2% |
News See All
Why SpaceX and J&J Stocks Are Falling Today — and What Wall Street Sees Next
Two Wall Street heavyweights are having a painful Tuesday, although their troubles have little in common. SpaceX (NASDAQ:SPCX) is sliding nearly 4%...
Options Volatility and Implied Earnings Moves Today, October 13, 2026
Today, several major companies are expected to report earnings: Citigroup (C), Domino’s Pizza (DPZ), JPMorgan Chase (JPM), Johnson & Johnson (JNJ),...
Johnson & Johnson Stock Falls Despite Beating Q3 Expectations – Here’s Why
Johnson & Johnson ($JNJ) reported better-than-expected third-quarter 2026 results on Tuesday, driven by strong pharmaceutical sales. However, JNJ s...
Will Johnson & Johnson Stock (JNJ) Rise or Fall After Q3 Earnings?
Johnson & Johnson stock was up slightly on Monday ahead of the company’s earnings report, which could be a strong catalyst for JNJ shares.
Johnson & Johnson Q3 Earnings on October 13: Analysts See 10% Upside in JNJ Stock
Medical group Johnson & Johnson ($JNJ) reports its Q3 earnings tomorrow – October 13. Wall Street expects the company to report earnings per share ...
Johnson & Johnson Stock Could Move by $9.51 after Q3 Results
Johnson & Johnson ($JNJ) is set to report its third-quarter 2026 results before the market opens on October 13. According to TipRanks options data,...
Options Volatility and Implied Earnings Moves This Week, October 13 – October 16, 2026
This week, several major companies will be reporting earnings. Among them are Bank of America (BAC), Johnson & Johnson (JNJ), JPMorgan Chase (JPM),...
Johnson & Johnson (JNJ) Survived the Stelara Cliff. Is 23.6 Times Earnings Too Much?
Replacing a blockbuster is the hardest job in the drug business. Johnson & Johnson (NYSE:JNJ) is in the middle of it, and the scoreboard looks oddly calm.
The Week That Was, The Week Ahead: Macro and Markets, October 11
U.S. stocks finished Friday higher, recovering from a technology selloff sparked by questions over OpenAI’s revenue figures. The Dow Jones Industri...
Hedge Fund Resource Center